Dr. Pallavi Kumar, MD
Claim this profileSinai Hospital of Baltimore
Studies Skin Cancer
Studies Endometrial Cancer
11 reported clinical trials
44 drugs studied
Area of expertise
1Skin Cancer
Stage IV
Stage III
HER2 positive
2Endometrial Cancer
Stage III
Stage IV
Stage I
Affiliated Hospitals
Clinical Trials Pallavi Kumar, MD is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting1 award Phase 2 & 323 criteria
More about Pallavi Kumar, MD
Clinical Trial Related2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Pallavi Kumar, MD has experience with
- Paclitaxel
- Carboplatin
- Pembrolizumab
- Trastuzumab
- Pertuzumab
- RenovoCath
Breakdown of trials Pallavi Kumar, MD has run
Skin Cancer
Endometrial Cancer
Ovarian Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Pallavi Kumar, MD specialize in?
Pallavi Kumar, MD focuses on Skin Cancer and Endometrial Cancer. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Pallavi Kumar, MD currently recruiting for clinical trials?
Yes, Pallavi Kumar, MD is currently recruiting for 8 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Pallavi Kumar, MD has studied deeply?
Yes, Pallavi Kumar, MD has studied treatments such as Paclitaxel, Carboplatin, Pembrolizumab.
What is the best way to schedule an appointment with Pallavi Kumar, MD?
Apply for one of the trials that Pallavi Kumar, MD is conducting.
What is the office address of Pallavi Kumar, MD?
The office of Pallavi Kumar, MD is located at: Sinai Hospital of Baltimore, Baltimore, Maryland 21215 United States. This is the address for their practice at the Sinai Hospital of Baltimore.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.